BioTuesdays
Lucid Psycheceuticals Logo

FSD Pharma to acquire Lucid Psycheceuticals

FSD Pharma (NASDAQ:HUGE; CSE:HUGE; FRA:0K9A) agreed to acquire all the shares of closely-held, Lucid Psycheceuticals, for approximately $9-million in FSD Pharma stock.  “Lucid has successfully developed a strong...

111 inc logo

111, Inc. deepens partnership with Bayer

111, Inc. (NASDAQ:YI) has expanded its existing partnership with Bayer Healthcare in China. The original partnership was signed in September 2020 and involved collaborating on drug commercialization initiatives in China...

Advaxis Biosight Logo

Advaxis and Biosight in merger pact

Advaxis (NASDAQ:ADXS) and closely held Biosight of Israel entered into a definitive merger agreement, with shareholders of Biosight becoming the majority holders of the combined company. Advaxis will be renamed Biosight...